Xizang Weixinkang Pharmaceutical (603676.SH) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Oct29

Xizang Weixinkang Pharmaceutical released FY2025 Q3 earnings on October 29 After-Market (BJT), actual revenue CNY 276.24 M, actual EPS CNY 0.0868

01:00

Xizang Weixinkang Pharmaceutical released FY2025 9 Months Earnings on October 29 After-Market BJT, actual revenue CNY 862.42 M, actual EPS CNY 0.5063

01:00

Oct22

Xizang Weixinkang Pharmaceutical FY2025 Q3 Earnings Release on October 30 After-Market BJT

00:56

Aug27

Xizang Weixinkang Pharmaceutical released FY2025 Semi-Annual Earnings on August 27 After-Market BJT, actual revenue CNY 586.17 M, actual EPS CNY 0.42

01:00

Xizang Weixinkang Pharmaceutical released FY2025 Q2 earnings on August 27 After-Market BJT, actual revenue CNY 290.36 M, actual EPS CNY 0.2194

01:00

Aug20

Xizang Weixinkang Pharmaceutical to Release FY2025 Semi-Annual Earnings on August 28, 2025 (BJT)

00:23

Schedules & Filings

Schedules

Filings

Nov26

Distribution Plan(CST)

Cash dividend 0.147 CNY

Distribution Plan(CST)

Cash dividend 0.147 CNY

Nov25

Distribution Plan(CST)

Cash dividend 0.147 CNY

View More

Stock List

Top Gainers

Top Decliners

Northbound Connect

Symbol

Price

%Chg

Change

View More